LOGO JPG.jpg
Cempra to Present at J.P. Morgan Healthcare Conference
04 janv. 2017 07h00 HE | Cempra, Inc.
CHAPEL HILL, N.C., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Receives Complete Response Letter From FDA For Solithromycin NDAs
29 déc. 2016 06h55 HE | Cempra, Inc.
CHAPEL HILL, N.C., Dec. 29, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Cempra, Inc. - CEMP
27 déc. 2016 14h52 HE | The Rosen Law Firm PA
NEW YORK, Dec. 27, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Cempra, Inc. securities...
LOGO JPG.jpg
Cempra Appoints Dr. David Zaccardelli as Acting Chief Executive Officer, Promotes Chief Commercial Officer David Moore to President
12 déc. 2016 09h01 HE | Cempra, Inc.
   —Leadership changes bolster manufacturing, regulatory and commercial expertise— —Cempra founder, president and CEO, Dr. Prabhavathi Fernandes, announces retirement from the company and...
Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Cempra, Inc. (NASDAQ: CEMP) Securities Case
05 déc. 2016 13h35 HE | Scott + Scott, Attorneys at Law, LLP
NEW YORK, Dec. 05, 2016 (GLOBE NEWSWIRE) -- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national investor rights law firm, reminds investors that January 3, 2017 is the last day to file...
LOGO JPG.jpg
Toyama Chemical (a Subsidiary of FUJIFILM Holdings Corporation) Begins Phase 3 Studies in Japan With Cempra’s Solithromycin
05 déc. 2016 08h00 HE | Cempra, Inc.
CHAPEL HILL, N.C., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Cempra, Inc. (NASDAQ: CEMP) Securities Case
14 nov. 2016 11h36 HE | Scott + Scott, Attorneys at Law, LLP
NEW YORK, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national investor rights law firm, reminds investors that January 3, 2017 is the last day to file...
LOGO JPG.jpg
Cempra to Present at Two Upcoming Investor Conferences
09 nov. 2016 07h30 HE | Cempra, Inc.
CHAPEL HILL, N.C., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
FDA Advisory Committee Votes That Efficacy Results of Cempra’s Solithromycin Outweigh Risks for Community-Acquired Bacterial Pneumonia
04 nov. 2016 22h40 HE | Cempra, Inc.
—FDA PDUFA dates December 27 & 28, 2016— CHAPEL HILL, N.C., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing...
LOGO JPG.jpg
Cempra Stock Trading Halted Today; FDA Advisory Committee to Discuss Solithromycin
04 nov. 2016 07h05 HE | Cempra, Inc.
CHAPEL HILL, N.C., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...